Consorteum Holdings Inc. (CSRH.OB) Secures Private Placement Financing
Consorteum Holdings, Inc. was pleased to announce this morning that it has reached an agreement to raise additional financing with…
Blog
Novelos Therapeutics, Inc. (NVLT.OB) Nearly Doubled in Price Since Coverage by QualityStocks Newsletter
Novelos Therapeutics Inc.’s shares have nearly doubled in price since the company was initially covered in QualityStocks’ FREE Daily Newsletter.…
National Automation Services, Inc. (NASV.PK) is “One to Watch”
National Automation Services, Inc. is a public holding company focused on designing, engineering, installing and maintaining automated control systems for…
Ready Mix Inc. (RMX) Works to Position Itself for a South-Western US Rebound
Risk is all part of the equation when it comes to investing. If a particular sector or company appears to…
Dynavax Technologies Corp. (DVAX) is “One to Watch”
Dynavax Technologies Corp. is a clinical-stage biopharmaceutical company committed to discovering and developing novel products to prevent and treat infectious…
Imagine Media Ltd. (IMLE.OB) Inks LOI to Acquire Biotech Firm DMI Life Sciences
Imagine Media Ltd. today announced it has signed a non-binding Letter of Intent to acquire DMI Life Sciences Inc., a…
NetSol Technologies, Inc. (NTWK) Goes Public
As a worldwide provider of global business services and enterprise application solutions, one of the strengths of NetSol Technologies Inc.…
GC China Turbine Corp. (GCHT.OB) Teams with Shenzhen Guohan Investment Group to Develop New Wind Farm
GC China Turbine Corp., China-based producer of advanced dual-blade wind turbines, revealed today that the Company has entered into a…
Anything Brands Online, Inc. (ANYT.PK) is “One to Watch”
Anything Brands Online, Inc./myFreightWorld.com is a business outsourcing company that sells technology, services, and wholesale truck, rail, and airfreight capacity.…
Genta Inc. (GETA.OB) Forms Strategic Alliance with MedCI to License Cancer Drug
Genta Inc., the biopharma company with a wide-ranging portfolio focused primarily on DNA/RNA and Small Molecule medicines, announced a strategic…